HK1006783A1 - Amorphous piretanide, piretanide polymorphis, process for their preparation and their use - Google Patents

Amorphous piretanide, piretanide polymorphis, process for their preparation and their use

Info

Publication number
HK1006783A1
HK1006783A1 HK98105624A HK98105624A HK1006783A1 HK 1006783 A1 HK1006783 A1 HK 1006783A1 HK 98105624 A HK98105624 A HK 98105624A HK 98105624 A HK98105624 A HK 98105624A HK 1006783 A1 HK1006783 A1 HK 1006783A1
Authority
HK
Hong Kong
Prior art keywords
piretanide
pct
sec
peak
date
Prior art date
Application number
HK98105624A
Other languages
English (en)
Inventor
Yuji Chikaraishi
Yoshihisa Matsuda
Makoto Otsuka
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03321695A external-priority patent/JP3532988B2/ja
Priority claimed from JP03321595A external-priority patent/JP3532987B2/ja
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of HK1006783A1 publication Critical patent/HK1006783A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Glass Compositions (AREA)
HK98105624A 1995-02-22 1998-06-18 Amorphous piretanide, piretanide polymorphis, process for their preparation and their use HK1006783A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP03321695A JP3532988B2 (ja) 1995-02-22 1995-02-22 ピレタニドの新規な結晶多形およびその製造方法
JP03321595A JP3532987B2 (ja) 1995-02-22 1995-02-22 新規な無晶形ピレタニドおよびその製造方法
PCT/IB1996/000254 WO1996026197A1 (en) 1995-02-22 1996-02-12 Amorphous piretanide, piretanide polymorphs, process for their preparation and their use

Publications (1)

Publication Number Publication Date
HK1006783A1 true HK1006783A1 (en) 1999-03-19

Family

ID=26371876

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105624A HK1006783A1 (en) 1995-02-22 1998-06-18 Amorphous piretanide, piretanide polymorphis, process for their preparation and their use

Country Status (15)

Country Link
US (1) US6096779A (ko)
EP (1) EP0812320B1 (ko)
KR (1) KR100419355B1 (ko)
CN (1) CN1072215C (ko)
AT (1) ATE194607T1 (ko)
BR (1) BR9607295A (ko)
CA (1) CA2213693C (ko)
DE (1) DE69609314T2 (ko)
DK (1) DK0812320T3 (ko)
ES (1) ES2150105T3 (ko)
GR (1) GR3034605T3 (ko)
HK (1) HK1006783A1 (ko)
MX (1) MX9706339A (ko)
PT (1) PT812320E (ko)
WO (1) WO1996026197A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
DE10013289A1 (de) * 2000-03-17 2001-09-20 Knoll Ag Torasemid enthaltende pharmazeutische Zubereitungen
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
MXPA04011427A (es) 2002-05-16 2005-02-17 Tibotec Pharm Ltd Formas seudopolimorficas de un inhibidor de proteasa del virus de inmunodeficiencia adquirida.
US20080234353A1 (en) * 2004-03-24 2008-09-25 Reynir Eyjolfsson Formulations of Ramipril
US20070098782A1 (en) * 2005-10-28 2007-05-03 Selamine Limited Ramipril Formulation
GB2431579A (en) * 2005-10-28 2007-05-02 Arrow Int Ltd Ramipril formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2419970C3 (de) * 1974-04-25 1980-06-12 Hoechst Ag, 6000 Frankfurt 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
JPS5283547A (en) * 1976-01-01 1977-07-12 Hoechst Ag Tertiary cyclic amine
DE2655331A1 (de) * 1976-12-07 1978-06-08 Hoechst Ag Zubereitungsformen von 3-n-pyrrolidino-4-phenoxy-5-sulfamyl-benzoesaeure und verfahren zu ihrer herstellung
DE3772091D1 (de) * 1986-04-29 1991-09-19 Hoechst Roussel Pharma Schichtenstruktur fuer die verabreichung von chemikalien mit kontrollierter abgaberate.
EP0465841A3 (en) * 1990-06-13 1992-10-14 Hoechst Aktiengesellschaft Quick acting pharmaceutical inhalation forms of diuretics
JPH05230044A (ja) * 1992-02-21 1993-09-07 Hoechst Japan Ltd ピレタニドの新規な結晶多形

Also Published As

Publication number Publication date
CN1072215C (zh) 2001-10-03
PT812320E (pt) 2000-12-29
GR3034605T3 (en) 2001-01-31
US6096779A (en) 2000-08-01
EP0812320A1 (en) 1997-12-17
MX9706339A (es) 1998-07-31
ATE194607T1 (de) 2000-07-15
DE69609314D1 (de) 2000-08-17
KR19980702374A (ko) 1998-07-15
KR100419355B1 (ko) 2004-06-04
BR9607295A (pt) 1997-11-25
WO1996026197A1 (en) 1996-08-29
CA2213693A1 (en) 1996-08-29
DE69609314T2 (de) 2001-06-13
ES2150105T3 (es) 2000-11-16
CA2213693C (en) 2008-04-15
DK0812320T3 (da) 2003-04-14
CN1175948A (zh) 1998-03-11
EP0812320B1 (en) 2000-07-12

Similar Documents

Publication Publication Date Title
EG20218A (en) Process for preparing of substituted 3 aminoquinuclidines
HU9501953D0 (en) Pharmaceutically active pyridine derivatives and process for the preparation thereof
ZA953701B (en) New atagonist compounds
CA2083179A1 (en) Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
HU210714A9 (en) Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
AU684914B2 (en) 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
GB9305295D0 (en) Therapeutic compounds
HK1006783A1 (en) Amorphous piretanide, piretanide polymorphis, process for their preparation and their use
EG19973A (en) Process for preparing of 4-aminopyridine derivatives
GB9310095D0 (en) Therapeutic compounds
IL132599A0 (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use
IL115301A0 (en) Process for the manufacture of starch products
AU1852395A (en) New tetrasubstituted derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
ES2006619A6 (es) Un metodo para preparar derivados de piridil-y pirimidil-piperazinas.
NZ294878A (en) Water soluble derivatives of epipodophyllotoxin and medicaments
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
NO975921D0 (no) Fremstilling av bicykloheksanderivater
GR3031267T3 (en) Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals.
AU4442389A (en) 1,2,3,4-tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments
IL108290A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
HUT51258A (en) Process for producing five-member nitrogenous heteroaromatic compounds
CA2208630A1 (en) 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20160211